Effects of oestrogen replacement therapy on serum C-reactive protein levels in hysterectomised women

dc.contributor.authors	Kiran, H; Kiran, G; Ekerbicer, HC; Guven, AM; Kilinc, M;
dc.date.accessioned	2020-02-27T08:40:45Z
dc.date.available	2020-02-27T08:40:45Z
dc.date.issued	2004
dc.identifier.citation	Kiran, H; Kiran, G; Ekerbicer, HC; Guven, AM; Kilinc, M; (2004). Effects of oestrogen replacement therapy on serum C-reactive protein levels in hysterectomised women. , 44, 134-131
dc.identifier.issn	0004-8666
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66701
dc.description.abstract	Conclusions: The data from the present study suggest that intranasal administration of E2 does not affect CRP levels, possibly by avoiding a hepatic first-pass effect. The possible cardiovascular protective role of intranasal oestrogen might be related to its effect of not increasing CRP levels.
dc.language	English
dc.publisher	BLACKWELL PUBLISHING
dc.title	Effects of oestrogen replacement therapy on serum C-reactive protein levels in hysterectomised women
dc.type	Article
dc.identifier.volume	44
dc.identifier.startpage	131
dc.identifier.endpage	134
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Ekerbiçer, Hasan Çetin
dc.identifier.wos	WOS:000230814900009
dc.contributor.author	H Kiran
dc.contributor.author	G Kiran
dc.contributor.author	Ekerbiçer, Hasan Çetin
dc.contributor.author	Am Guven
dc.contributor.author	M Kilinc